Who Owns Alterity Therapeutics Stock?
NASDAQ: ATHEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 2.07%
- Held by insiders
- 0.00%
- Institutional holders
- 24
- Institutions 2.1%
- Insiders 0.0%
- Public and other 97.9%
Who owns Alterity Therapeutics stock?
Institutional investors own about 2.1% of Alterity Therapeutics's shares, spread across 24 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of ATHE.
The largest institutional holders are Twin Lakes Capital Management, LLC (0.73%), Morgan Stanley (0.33%) and Greenleaf Trust (0.32%). Together, the top 10 institutions control 2.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ATHE positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ATHE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Twin Lakes Capital Management, LLC | 139.26K | 0.73% | 0.0% |
| Morgan Stanley | 63.06K | 0.33% | +8.0% |
| Greenleaf Trust | 62.00K | 0.32% | +93.8% |
| HB Wealth Management, LLC | 58.46K | 0.31% | 0.0% |
| Citadel Advisors Llc | 37.60K | 0.20% | +87.3% |
| HRT Financial LP | 17.29K | 0.09% | +100.0% |
| BNP Paribas Financial Markets | 10.24K | 0.05% | +50.4% |
| Gamma Investing LLC | 2.31K | 0.01% | +24.4% |
| Rhumbline Advisers | 2.01K | 0.01% | +2.0% |
| Acadian Asset Management. LLC | 1.86K | 0.01% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ATHE
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.16K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Alterity Therapeutics?
Twin Lakes Capital Management, LLC is the largest institutional shareholder of ATHE, owning 0.73% of shares outstanding (139.26K shares) as of its latest 13F filing.
What percentage of Alterity Therapeutics is owned by institutions?
Institutions own about 2.1% of ATHE shares and 2.1% of the public float.
How much of Alterity Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.00% of ATHE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.